Timing for repeated treatment of hyperthyroid disease with radioactive iodine after initial treatment failure

Clinical Nuclear Medicine

Volumn 26, Issue 1, 2001, Pages 1-5

  Gayed, Isis ^a,b   Wendt, Juliet ^a   Haynie, Thomas ^a   Dhekne, Ramesh ^a   Moore, Warren ^a  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

Hyperthyroidism; Outcomes; Radioactive Iodine; Treatment Failure

Indexed keywords

RADIOACTIVE IODINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; RADIATION HAZARD; RETROSPECTIVE STUDY; THYROID FUNCTION TEST; TREATMENT FAILURE;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; GOITER; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RETREATMENT; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT FAILURE;

EID: 0035190468     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200101000-00001     Document Type: Article

References (28)

1. Long term follow up study of compensated low-dose I-131 therapy for Graves' disease
2. Radioiodine treatment outcomes in thyroid glands previously irradiated for Graves' hyperthyroidism
3. Four to twenty-four hour uptake ratio: An index of rapid iodine-131 turnover in hyperthyroidism
4. The treatment of hyperthyroidism with iodine-131
5. Risks from radioiodine treatment of thyrotoxicosis
6. Current status of radioiodine (I-131) treatment of hyperthyroidism
7. Treatment of hyperthyroidism with radioactive iodine
8. Radioiodine and the immune system
9. Two mechanisms for hypothyroidism after I-131 therapy
10. Treatment of hyperthyroidism with a large initial dose of sodium iodide I-131
11. Very low doses of radioiodine for hyperthyroidism
12. A simplified method for treating Graves' disease with radioactive I-131
13. Influence of compensated radioiodine therapy on thyroid volume and incidence of hypothyroidism in Graves' disease
14. Longterm results of two schedules of radioiodine treatment for toxic multinodular goiter
15. Long term follow-up of treated hyperthyroid and hypothyroid patients
16. Low dosage I-131 therapy of thyrotoxicosis (diffuse goiters). A five years follow-up study
17. Optimal Iodine-131 dose for eliminating hyperthyroidism in Graves' disease
18. International radioiodine ablation in Graves' disease
19. Ablative radioiodine therapy for hyperthyroidism: Long-term follow-up study
20. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease
21. Usage of quantitative static scintigraphy of the thyroid gland in defining the therapeutical dose of radioiodine
22. Changes in thyroid volume in response to radioactive iodine for Graves' hyperthyroidism correlated with activity of thyroid stimulating antibody and treatment outcome
23. Treatment of hyperthyroidism with radioiodine: Adjunctive therapy with anthithyroid drugs considered
24. Outcome following radioactive iodine therapy in Graves' disease
25. I-131 treatment of diffuse and nodular toxic goiter with or without antithyroid agents
26. Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than with radioactive iodine in Graves' disease
27. Discriminant factors affecting early outcome of radioiodine treatment for Graves' disease